US Stock MarketDetailed Quotes

OKYO Pharma (OKYO)

Watchlist
  • 1.660
  • +0.100+6.41%
Close May 1 16:00 ET
  • 1.660
  • 0.0000.00%
Post 16:10 ET
87.12MMarket Cap-8.74P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

OKYO Pharma (OKYO) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Mar 31, 2025
(FY)Mar 31, 2024
(FY)Mar 31, 2023
(FY)Mar 31, 2022
(FY)Mar 31, 2021
(FY)Mar 31, 2020
(FY)Mar 31, 2019
(FY)Mar 31, 2018
(FY)Mar 31, 2017
(FY)Mar 31, 2016
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
80.92%-1.81M
-23.33%-9.49M
-40.73%-7.7M
-241.71%-5.47M
-33.12%-1.6M
39.59%-1.2M
-24.77%-1.99M
-144.89%-1.59M
-0.06%-651.27K
91.85%-650.88K
Net income from continuing operations
52.57%-7.97M
-26.49%-16.8M
-113.65%-13.28M
-84.03%-6.22M
-108.50%-3.38M
66.95%-1.62M
82.66%-4.9M
-11,584.05%-28.27M
70.50%-241.93K
90.06%-820.17K
Operating gains losses
-455.74%-191.26K
38.64%53.76K
235.79%38.78K
-1,036.41%-28.56K
-118.06%-2.51K
1,292.03%13.92K
-100.00%-1.17K
--26.39M
----
-127.31%-26.9K
Depreciation and amortization
-33.70%2.56K
1.82%3.87K
62.89%3.8K
-82.22%2.33K
119.28%13.11K
2,644.97%5.98K
--217.8166
--0
----
----
Other non cash items
-42.62%1.99M
2,912.53%3.46M
86.31%114.99K
-25.64%61.72K
93.73%83.01K
-98.40%42.85K
991.02%2.69M
--246.21K
----
28.53%-12.36K
Change In working capital
-39.06%1.63M
-32.35%2.67M
485.38%3.95M
-197.99%-1.02M
460.14%1.04M
5.50%186.53K
395.04%176.81K
108.35%35.72K
-491.19%-427.71K
246.35%109.34K
-Change in receivables
----
--0
--0
-86.65%27.38K
267.09%205.07K
6.41%-122.73K
-165.98%-131.14K
155.03%198.76K
-584.16%-361.21K
1,536.60%74.61K
-Change in payables and accrued expense
-22.97%1.72M
-41.00%2.23M
1,616.75%3.78M
-129.66%-249.09K
171.54%839.78K
0.43%309.27K
288.88%307.95K
-145.16%-163.04K
-291.48%-66.51K
149.96%34.73K
-Change in other current assets
-120.53%-90.4K
162.50%440.26K
120.91%167.72K
---802.15K
----
----
----
----
----
----
Cash from discontinued investing activities
0
Operating cash flow
80.92%-1.81M
-23.33%-9.49M
-40.73%-7.7M
-241.71%-5.47M
-33.12%-1.6M
39.59%-1.2M
-24.77%-1.99M
-144.89%-1.59M
-0.06%-651.27K
54.08%-650.88K
Investing cash flow
Cash flow from continuing investing activities
-1.21K
0
-254.46%-5.92K
90.79%-1.67K
86.35%-18.11K
-9,931.22%-132.67K
-1.32K
0
87.85%-335.18K
Capital expenditure reported
----
----
----
----
----
----
----
----
----
85.28%-405.59K
Net PPE purchase and sale
---1.21K
--0
-254.46%-5.92K
75.96%-1.67K
---6.94K
--0
---1.32K
--0
----
1,552.67%70.41K
Net other investing changes
----
----
----
----
91.58%-11.17K
---132.67K
----
----
----
----
Cash from discontinued investing activities
Investing cash flow
---1.21K
--0
-254.46%-5.92K
90.79%-1.67K
86.35%-18.11K
-9,931.22%-132.67K
---1.32K
--0
----
87.85%-335.18K
Financing cash flow
Cash flow from continuing financing activities
-57.22%2.66M
-33.41%6.21M
332.99%9.32M
-72.49%2.15M
712.50%7.83M
963.31K
0
-96.66%12.36K
Net issuance payments of debt
--950K
--0
--2M
--0
27,839.94%7.58M
---27.33K
--0
----
----
-28.53%12.36K
Net common stock issuance
-72.53%1.71M
-15.22%6.21M
--7.32M
--0
-76.78%230.02K
--990.64K
--0
----
----
----
Proceeds from stock option exercised by employees
----
--0
--0
13,468.18%2.15M
--15.87K
--0
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
-57.22%2.66M
-33.41%6.21M
332.99%9.32M
-72.49%2.15M
712.50%7.83M
--963.31K
--0
----
----
-96.66%12.36K
Net cash flow
Beginning cash position
-79.56%826.85K
49.79%4.05M
-60.80%2.7M
2,825.59%6.89M
-62.48%235.49K
-76.03%627.62K
-40.60%2.62M
0.23%4.41M
-29.89%4.4M
-40.36%6.27M
Current changes in cash
125.70%843.6K
-302.32%-3.28M
148.91%1.62M
-153.42%-3.32M
1,771.58%6.21M
81.35%-371.42K
-24.85%-1.99M
-144.89%-1.59M
33.11%-651.27K
74.42%-973.71K
Effect of exchange rate changes
-272.53%-109.55K
122.88%63.5K
68.18%-277.54K
-295.89%-872.14K
2,249.98%445.22K
---20.71K
----
----
--0
30.64%-171.84K
End cash Position
88.78%1.56M
-79.56%826.85K
49.79%4.05M
-60.80%2.7M
2,825.59%6.89M
-62.48%235.49K
-77.70%627.56K
-24.91%2.81M
-26.93%3.75M
-20.67%5.13M
Free cash flow
80.91%-1.81M
-23.24%-9.49M
-40.80%-7.7M
-240.34%-5.47M
-33.70%-1.61M
39.63%-1.2M
-24.85%-1.99M
-144.89%-1.59M
38.38%-651.27K
74.70%-1.06M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
Unqualified Opinion with Explanatory Notes
Unqualified Opinion with Explanatory Notes
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
--
(FY)Mar 31, 2025(FY)Mar 31, 2024(FY)Mar 31, 2023(FY)Mar 31, 2022(FY)Mar 31, 2021(FY)Mar 31, 2020(FY)Mar 31, 2019(FY)Mar 31, 2018(FY)Mar 31, 2017(FY)Mar 31, 2016
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 80.92%-1.81M-23.33%-9.49M-40.73%-7.7M-241.71%-5.47M-33.12%-1.6M39.59%-1.2M-24.77%-1.99M-144.89%-1.59M-0.06%-651.27K91.85%-650.88K
Net income from continuing operations 52.57%-7.97M-26.49%-16.8M-113.65%-13.28M-84.03%-6.22M-108.50%-3.38M66.95%-1.62M82.66%-4.9M-11,584.05%-28.27M70.50%-241.93K90.06%-820.17K
Operating gains losses -455.74%-191.26K38.64%53.76K235.79%38.78K-1,036.41%-28.56K-118.06%-2.51K1,292.03%13.92K-100.00%-1.17K--26.39M-----127.31%-26.9K
Depreciation and amortization -33.70%2.56K1.82%3.87K62.89%3.8K-82.22%2.33K119.28%13.11K2,644.97%5.98K--217.8166--0--------
Other non cash items -42.62%1.99M2,912.53%3.46M86.31%114.99K-25.64%61.72K93.73%83.01K-98.40%42.85K991.02%2.69M--246.21K----28.53%-12.36K
Change In working capital -39.06%1.63M-32.35%2.67M485.38%3.95M-197.99%-1.02M460.14%1.04M5.50%186.53K395.04%176.81K108.35%35.72K-491.19%-427.71K246.35%109.34K
-Change in receivables ------0--0-86.65%27.38K267.09%205.07K6.41%-122.73K-165.98%-131.14K155.03%198.76K-584.16%-361.21K1,536.60%74.61K
-Change in payables and accrued expense -22.97%1.72M-41.00%2.23M1,616.75%3.78M-129.66%-249.09K171.54%839.78K0.43%309.27K288.88%307.95K-145.16%-163.04K-291.48%-66.51K149.96%34.73K
-Change in other current assets -120.53%-90.4K162.50%440.26K120.91%167.72K---802.15K------------------------
Cash from discontinued investing activities 0
Operating cash flow 80.92%-1.81M-23.33%-9.49M-40.73%-7.7M-241.71%-5.47M-33.12%-1.6M39.59%-1.2M-24.77%-1.99M-144.89%-1.59M-0.06%-651.27K54.08%-650.88K
Investing cash flow
Cash flow from continuing investing activities -1.21K0-254.46%-5.92K90.79%-1.67K86.35%-18.11K-9,931.22%-132.67K-1.32K087.85%-335.18K
Capital expenditure reported ------------------------------------85.28%-405.59K
Net PPE purchase and sale ---1.21K--0-254.46%-5.92K75.96%-1.67K---6.94K--0---1.32K--0----1,552.67%70.41K
Net other investing changes ----------------91.58%-11.17K---132.67K----------------
Cash from discontinued investing activities
Investing cash flow ---1.21K--0-254.46%-5.92K90.79%-1.67K86.35%-18.11K-9,931.22%-132.67K---1.32K--0----87.85%-335.18K
Financing cash flow
Cash flow from continuing financing activities -57.22%2.66M-33.41%6.21M332.99%9.32M-72.49%2.15M712.50%7.83M963.31K0-96.66%12.36K
Net issuance payments of debt --950K--0--2M--027,839.94%7.58M---27.33K--0---------28.53%12.36K
Net common stock issuance -72.53%1.71M-15.22%6.21M--7.32M--0-76.78%230.02K--990.64K--0------------
Proceeds from stock option exercised by employees ------0--013,468.18%2.15M--15.87K--0----------------
Cash from discontinued financing activities
Financing cash flow -57.22%2.66M-33.41%6.21M332.99%9.32M-72.49%2.15M712.50%7.83M--963.31K--0---------96.66%12.36K
Net cash flow
Beginning cash position -79.56%826.85K49.79%4.05M-60.80%2.7M2,825.59%6.89M-62.48%235.49K-76.03%627.62K-40.60%2.62M0.23%4.41M-29.89%4.4M-40.36%6.27M
Current changes in cash 125.70%843.6K-302.32%-3.28M148.91%1.62M-153.42%-3.32M1,771.58%6.21M81.35%-371.42K-24.85%-1.99M-144.89%-1.59M33.11%-651.27K74.42%-973.71K
Effect of exchange rate changes -272.53%-109.55K122.88%63.5K68.18%-277.54K-295.89%-872.14K2,249.98%445.22K---20.71K----------030.64%-171.84K
End cash Position 88.78%1.56M-79.56%826.85K49.79%4.05M-60.80%2.7M2,825.59%6.89M-62.48%235.49K-77.70%627.56K-24.91%2.81M-26.93%3.75M-20.67%5.13M
Free cash flow 80.91%-1.81M-23.24%-9.49M-40.80%-7.7M-240.34%-5.47M-33.70%-1.61M39.63%-1.2M-24.85%-1.99M-144.89%-1.59M38.38%-651.27K74.70%-1.06M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory NotesUnqualified Opinion with Explanatory NotesUnqualified Opinion with Explanatory NotesUnqualified Opinion with Explanatory Notes------------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +17.90%
Sample Name
Sample Code
 +13.59%
Sample Name
Sample Code
 +12.81%
4
VanEck Oil Services ETF
OIH
+11.45%
5
United Sts 12 Month Oil Fd Lp Unit Ben Int
USL
+9.96%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +11.87%
Sample Name
Sample Code
 +6.69%
Sample Name
Sample Code
 +6.27%
4
KE Holdings
BEKE
+5.44%
5
New Oriental
EDU
+4.10%
View More
Middle East conflict spreads to the stock market! How should investors respond?
On May 1, the more than two-month-long military conflict involving the US, Israel, and Iran will reach a legal milestone, potentially increa Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -